Dow Up 0.19% Nasdaq Up 0.56%

Novo Nordisk A/S (NVO)

-NYSE
44.35 Down 0.39(0.87%) 4:06PM EST
- NYSE Real Time Price
Prev Close:44.74
Open:44.35
Bid:44.31 x 1400
Ask:44.32 x 1100
1y Target Est:49.37
Beta:0.89
Next Earnings Date:N/A
Day's Range:44.25 - 44.53
52wk Range:34.30 - 49.11
Volume:1,024,966
Avg Vol (3m):1,465,880
Market Cap:115.93B
P/E (ttm):26.85
EPS (ttm):1.65
Div & Yield:0.61 (1.40%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVODown 0.87%115.93B
LLYDown 0.61%71.45B
PFE 0.00%191.79B
SNYDown 3.16%122.21B

Key Statistics

Forward P/E (1 yr):22.38
P/S (ttm):8.10
Ex-Dividend Date:21-Mar-14

Analysts

Annual EPS Est (Dec-14) :1.73
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.00

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback